Search Within

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3739-3759
Authors: Natasja M.W.J. de Bruin and Chris G Kruse

Selective 5-HT7 Receptor Activation May Enhance Synaptic Plasticity Through N-methyl-D-aspartate (NMDA) Receptor Activity in the Visual Cortex

Journal: Current Neurovascular Research
Volume: 13,Issue: 4
Page: 321-328
Authors: Kangjian Xiang, Xuefei Zhao, Youjun Li, Liang Zheng, Jue Wang and Yan-Hai Li

Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 14
Page: 2064-2071
Authors: Felix-Martin Werner and Rafael Covenas

AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models

Journal: Current Alzheimer Research
Volume: 14,Issue: 3
Page: 268-294
Authors: Alexandre V. Ivachtchenko, Yan A. Ivanenkov, Mark S. Veselov and I. M. Okun

In silico Modeling Studies of 5-HT2B Antagonistic Activity of 2-(2- phenylethyl)chromone Derivatives from Cucumis melo Seeds

Journal: Letters in Drug Design & Discovery
Volume: 13,Issue: 8
Page: 840-844
Authors: Sabrin R. M. Ibrahim, Gamal A. Mohamed and Shahenda M. El-Messery

Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3725-3731
Authors: Andrew C. McCreary and Adrian Newman-Tancredi

Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs

Journal: Current Drug Therapy
Volume: 10,Issue: 2
Page: 66-81
Authors: Felix-Martin Werner and Rafael Coveñas

Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 18,Issue: 7
Page: 685-692
Authors: Man Luo, Terry-Elinor Reid and Xiang Simon Wang

Investigation of 5-HT2A gene expression in PBMCs of patients with allergic asthma

Journal: Inflammation & Allergy-Drug Targets (Discontinued)
Volume: 14,Issue: 1
Page: 60-64
Authors: Ghasem Ahangari, Somayeh Emadi Koochak, Leila Mohammadi Amirabad and Gholamreza Derkhshan Deilami

Chronic Effects of Cocaine on Dopaminergic and Serotonergic Systems of Rats

Journal: Current Molecular Imaging (Discontinued)
Volume: 4,Issue: 1
Page: 43-52
Authors: Chun-Kai Fang, Hui-Yen Chuang, Wei-Hsun Wang, Ren-Shyun Liu, Shyh-Jen Wang and Jeng-Jong Hwang

Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 14
Page: 2093-2116
Authors: Agnieszka Nikiforuk

Atypical Neurotransmitters and the Neurobiology of Depression

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 8
Page: 1001-1011
Authors: Samia Regiane Joca, Fabricio Araujo Moreira and Gregers Wegener

Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems

Journal: Current Neuropharmacology
Volume: 13,Issue: 4
Page: 435-444
Authors: De Rossi Pietro, Chiara Chiapponi and Gianfranco Spalletta

Atypical antipsychotics and inverse agonism at 5-HT2 receptors

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3732-3738
Authors: Laura C. Sullivan, William P Clarke and Kelly A. Berg

Chromatographic QSAR of 3-[ω-(4-Arylpiperazin-1-yl)alkyl]methylpyrimido-[ 5,4-c]quinolin-4(3H)-ones for the 5-HT1A Receptor Characterization

Journal: Current Analytical Chemistry
Volume: 12,Issue: 6
Page: 537-544
Authors: Wieslawa Lewgowd, Marta Szumilak and Grazyna Zydek

Previous     Next

Go To   Results 1 - 15 of 2618